Center for Vitaliserende Samtaler ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.3% 1.3% 1.3% 1.3% 1.3%  
Bankruptcy risk  12.1% 7.7% 11.3% 25.2% 22.7%  
Credit score (0-100)  19 30 20 2 4  
Credit rating  BB BB BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 739 0  
Gross profit  605 440 609 657 137  
EBITDA  170 -74.8 74.3 -260 21.1  
EBIT  170 -74.8 74.3 -260 21.1  
Pre-tax profit (PTP)  164.9 -77.1 73.9 -259.7 21.1  
Net earnings  126.8 -64.4 57.6 -263.7 -78.5  
Pre-tax profit without non-rec. items  165 -77.1 73.9 -260 21.1  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  177 12.3 69.9 -178 -257  
Interest-bearing liabilities  0.1 33.3 33.3 124 254  
Balance sheet total (assets)  292 119 212 0.5 1.8  

Net Debt  -217 -7.1 -99.9 123 252  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 739 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% -100.0%  
Gross profit  605 440 609 657 137  
Gross profit growth  0.0% -27.2% 38.4% 8.0% -79.2%  
Employees  1 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -769.9 -70.5  
Balance sheet total (assets)  292 119 212 0 2  
Balance sheet change%  0.0% -59.1% 77.7% -99.8% 296.7%  
Added value  169.6 -74.8 74.3 510.1 91.6  
Added value %  0.0% 0.0% 0.0% 69.1% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 -1.0  
EBIT trend  1.0 -1.0 1.0 -1.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% -35.2% 0.0%  
EBIT %  0.0% 0.0% 0.0% -35.2% 0.0%  
EBIT to gross profit (%)  28.0% -17.0% 12.2% -39.5% 15.4%  
Net Earnings %  0.0% 0.0% 0.0% -35.7% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% -35.7% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% -35.2% 0.0%  
ROA %  58.1% -36.4% 44.9% -132.8% 9.7%  
ROI %  95.9% -67.3% 100.1% -214.7% 10.8%  
ROE %  71.7% -68.1% 140.0% -749.3% -6,996.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  60.6% 10.3% 32.9% -99.7% -99.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 22.2% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 22.1% 0.0%  
Net int. bear. debt to EBITDA, %  -128.0% 9.5% -134.6% -47.5% 1,192.9%  
Gearing %  0.0% 269.4% 47.5% -69.5% -98.8%  
Net interest  0 0 0 0 0  
Financing costs %  18,156.9% 14.0% 1.6% 0.1% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.5 1.1 1.5 0.0 5.5  
Current Ratio  2.5 1.1 1.5 0.0 5.5  
Cash and cash equivalent  217.2 40.3 133.2 0.5 1.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.1% 0.0%  
Net working capital  176.8 12.3 69.9 -163.4 1.5  
Net working capital %  0.0% 0.0% 0.0% -22.1% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  170 -75 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  170 -75 0 0 0  
EBIT / employee  170 -75 0 0 0  
Net earnings / employee  127 -64 0 0 0